NBIX NEUROCRINE BIOSCIENCES INC
FollowCOM (common), issuer CIK 914475
630 managers (650 13F filers) reported a position in NBIX shares at 2025-09-30, 97,211,652 shares in all. 113 filers opened a position and 51 filers sold out during the quarter.
- Managers
- 630
- 13F filers
- 650
- New
- 113
- Added
- 220
- Reduced
- 219
- Sold out
- 51
- Shares held by filers
- 97,211,652
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- JPMORGAN CHASE & CO(group JPMORGAN CHASE & CO)
5,300,390 shares, 5.2% in a 13G/A as of 2026-09-30,0000019617-26-000371
Accepted , ingested
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2025
Filers in the available 13F reports with a share position at 2025-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
Events
JPMORGAN CHASE & CO reported 5,300,390 NBIX shares, 5.2% of the class, as of 2026-09-30, in a 13G/A filed 2026-10-15. 0000019617-26-000371
Accepted , ingestedROBERTS EIRY reported holdings of NBIX shares in a Form 3 filed 2026-10-07. 0001727606-26-000004
Accepted , ingested